Concomitant Use of Apremilast for the Treatment of Active RA Despite TNF-Inhibition and Methotrexate- CATARA (CATARA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01204138
Recruitment Status : Withdrawn (decision of sponsor to withdraw before initiation; 0 patients enrolled)
First Posted : September 17, 2010
Last Update Posted : February 5, 2016
Celgene Corporation
Information provided by (Responsible Party):
Mark Genovese, Stanford University

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Actual Primary Completion Date : August 2011
  Actual Study Completion Date : December 2011